Health
Small molecule, big potential for treating prostate cancer – MIT News
A team of researchers led by MIT professor Angela Koehler identified a CDK9 inhibitor that could be developed into a treatment for castration-resistant prostate…
Prostate cancer growth is often driven by male sex hormones called androgens. Hormone therapy is commonly administered to lower the level of androgens in the body, but relapse is common when the cancer cells develop resistance to these therapies.
A multidisciplinary team of cancer researchers led by Angela Koehler, the Samuel A. Goldblith Career Development Professor in Applied Biology and a member of MITs Koch Institute for Integrative Cancer Research, has identified a small molecule that can selectively…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025
-
Business23 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News22 hours agoThe Almond Ashes sees Australia and India mix business and cricket